Tonix Pharmaceuticals Stock (NASDAQ: TNXP) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 2.364M |
Day Range | - - - |
52 Wk Range | 0.120 - 2.240 |
Market Cap | $16.338M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 1.56% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tonix Pharmaceuticals (NASDAQ: TNXP) through any online brokerage.
Other companies in Tonix Pharmaceuticals’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Dominari Holdings (NASDAQ:DOMH).
The latest price target for Tonix Pharmaceuticals (NASDAQ: TNXP) was reported by Dawson James on Wednesday, February 28, 2024. The analyst firm set a price target for 3.00 expecting TNXP to rise to within 12 months (a possible 1654.39% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Tonix Pharmaceuticals (NASDAQ: TNXP) is $0.171 last updated May 10, 2024 at 7:52 PM EDT.
There are no upcoming dividends for Tonix Pharmaceuticals.
Tonix Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Tonix Pharmaceuticals.
Tonix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.